Results 81 to 90 of about 4,764 (176)

Catestatin as a predictor for cardiac death in heart failure with mildly reduced and preserved ejection fraction

ESC Heart Failure
Aims Endogenous catecholamine release‐inhibitory peptide catestatin has been associated with heart failure (HF). This subgroup analysis of our cohort of HF compared the different effects of catestatin as a predictor for cardiac outcomes in patients with ...
Song‐Yun Chu, Fen Peng, Jie Wang, Lin Liu, Jing Zhao, Xiao‐Ning Han, Wen‐Hui Ding   +6 more
doaj   +1 more source

LV Strain Superiority Over LVEF in HFmrEF

JACC: Advances, 2023
Giuseppe Galati, Olga Germanova, Roberto Franco Enrico Pedretti   +2 more
openaire   +1 more source

Sex differences in mortality and hospitalization in heart failure with preserved and mid-range ejection fraction: a systematic review and meta-analysis of cohort studies

Frontiers in Cardiovascular Medicine
IntroductionThe influence of sex on the prognosis of heart failure with preserved or intermediate ejection fraction (HFpEF and HFmrEF) remains uncertain.
You Deng, Jun Zhang, Jitao Ling, Qingwen Hu, Tianggang Song, Yi Xu, Menglu Liu, Yuting Wu, Kaibo Mei, Jiawei Chen, Huilei Zhao, Xiao Liu   +11 more
doaj   +1 more source

Coronary Chronic Total Occlusions Affect Long‐Term Prognosis in Heart Failure With Mildly Reduced Ejection Fraction

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background This study investigates the prevalence and prognostic impact of coronary chronic total occlusions (CTO) in patients with heart failure with mildly reduced ejection fraction (HFmrEF).
Michael Behnes, Moritz Schmidberger, Kambis Mashayekhi, Giuseppe Vadalà, Alice Moroni, Juan‐Luis Guiterrez‐Chico, Mohamed Ayoub, Evald Høj Christiansen, Stylianos Pyxaras, Alexander Bufe, Florian Krötz, Alexander Schmitt, Felix Lau, Marielen Reinhardt, Jan Forner, Jonas Dudda, Noah Abel, Mila Kathrin Hoepfner, Cedric Aubel, Mohammad Abumayyaleh, Kathrin Weidner, Ibrahim Akin, Tobias Schupp   +22 more
doaj   +1 more source

Electrocardiography-based artificial intelligence predicts the upcoming future of heart failure with mildly reduced ejection fraction

Frontiers in Cardiovascular Medicine
BackgroundHeart failure with mildly reduced ejection fraction (HFmrEF) has emerged as the predominant subtype of heart failure (HF). This study aimed to develop artificial intelligence (AI)-electrocardiography (ECG) to identify and predict the prognosis ...
Dae-Young Kim, Sang-Won Lee, Dong-Ho Lee, Sang-Chul Lee, Sang-Chul Lee, Ji-Hun Jang, Sung-Hee Shin, Dae-Hyeok Kim, Dae-Hyeok Kim, Wonik Choi, Wonik Choi, Yong-Soo Baek, Yong-Soo Baek, Yong-Soo Baek   +13 more
doaj   +1 more source

HFmrEF: Közepes ejekciós frakciójú szívelégtelenség [PDF]

Cardiologia Hungarica, 2019
openaire   +3 more sources

Effect of Finerenone on the KCCQ in Patients With HFmrEF/HFpEF: A Prespecified Analysis of FINEARTS-HF.

Journal of the American College of Cardiology
Patients with heart failure (HF) are limited by symptoms and have impaired quality of life. The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a patient-reported outcome measure that enables evaluation of the effect of HF and the impact of new therapies on health status in patients with HF.This prespecified analysis of FINEARTS-HF (Finerenone Trial
Yang, Mingming, Henderson, Alasdair, Talebi, Atefeh, Atherton, John, Chiang, Chern-En, Chopra, Vijay, Comin-Colet, Josep, Kosiborod, Mikhail, Kerr Saraiva, Jose, Claggett, Brian, Desai, Akshay, Kolkhof, Peter, Viswanathan, Prabhakar, Lage, Andrea, Lam, Carolyn S.P., Senni, Michele, Shah, Sanjiv, Rohwedder, Katja, Voors, Adriaan, Zannad, Faiez, Pitt, Bertram, Vaduganathan, Muthiah, Jhund, Pardeep, Solomon, Scott, McMurray, John J.V.   +24 more
openaire   +7 more sources

Heart Failure With Mildly Reduced Ejection Fraction: A Heart Failure Society of America Scientific Statement. [PDF]

J Card Fail
Wilcox JE, Lund LH, Cox ZL, Ho JE, Lam CSP, Sharma K, Borlaug BA.   +6 more
europepmc   +1 more source

Cost-Effectiveness of Sodium-Glucose Co-Transporter-2 Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors by Ejection Fraction and Drug Pricing in the United States: A Systematic Review. [PDF]

Circ Popul Health Outcomes
Alfie TJ, Wasfy JH, Kazi DS, Januzzi JL, Bellows BK, Cohen LP.   +5 more
europepmc   +1 more source

Comparative clinical outcomes and safety of finerenone, SGLT2 inhibitors, RAS inhibitors and ARNI in heart failure with preserved or mildly reduced ejection fraction: a systematic review and network meta-analysis. [PDF]

Front Pharmacol
Fu Z, Chen X, Liu H, Yang J, Jin T, Liu T, Ta G.   +6 more
europepmc   +1 more source